Comparison of molecular subtype distribution in triple negative inflammatory and non inflammatory breast cancers

General, Physician Resources

Inflammatory Breast Cancer, otherwise known as IBC, has a very poor prognosis due to its high rate of metastasis. Seven (7) sub-types of Triple Negative Breast Cancer (TNBC) have been identified in a recent study by Lehmann and colleagues. “Our data show that,...

Pink+

Physician Resources

The IBC Network is honored to share this guest post from  Oliver Bogler, Ph.D. He clearly outlines the gaps in research and how we can push to move the entire field of breast cancer advocacy a stage further. We hope you share this post and we look forward to your...

Statin and Inflammatory Breast Cancer

General, Physician Resources

The following is an introduction written by Dr. Ueno director of the Morgan Welch Clinic at MD Anderson commenting on an article ran in Science November 29, 2013.   We are very familiar with the desire of Dr. Ueno to research how statin can impact recurrence of breast...

Suites of Hope: Condo for Cancer Patients

Patient Resources

Every so often, we get the pleasure of hearing a truly moving story of someone that has been impacted by Breast Cancer or IBC and has changed the world around them. Well, Rachel Midgett and her family have done just that. Rachel was diagnosed with Stage IV breast...

Hold the Pink, Take Out Breast Cancer

Guest Blog

Kathleen K. Strosser has been living with Stage IV Inflammatory Breast Cancer since April, 2009. She is currently on a new chemotherapy agent approved just this past February. Kadcyla (Genentech) is a combination of herceptin and emtansine, and has far fewer side...